Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × atezolizumab × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 9 Mesothelioma, Malignant 7 Solid Tumor 6 Advanced Solid Tumor 6 Advanced Solid Tumors 3 Mesothelioma 2 Melanoma 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Merkel Cell 2 Urinary Bladder Neoplasms 1 Treatment-Refractory Solid Tumors 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumour 1 Solid Tumor, Adult 1 Small Cell Lung Carcinoma 1 Select Advanced Solid Tumors 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Locally Advanced or Metastatic Solid Tumors 1 Locally Advanced Solid Tumors 1 Locally Advanced Solid Tumor 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

pembrolizumab 6 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 niraparib 1 neotil 1 necitumumab 1 leronlimab 1 lenvatinib 1 atezolizumab 1 abemaciclib 1 Yoga 1 Watchful Waiting 1 Valganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06003621 2024-11-15

MoST-TAP

Omico

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡